Prime editing as a therapy for LMNA-associated dilated cardiomyopathy

13 June 2026 (12:32 - 12:35)

Organised by:

About the speaker

Miss Anoek Rooijakkers

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

9 More presentations in this session

Presentation thumbnail

Investigating oxpl-mediated vascular inflammation in humanized Lp(a) transgenic mice: a preclinical study toward novel therapeutic strategies

Mr V. Antoniou (Athens, GR)

Presentation thumbnail

Variant-specific drug responses in FH: an ex vivo pilot study

Mr R. Graca (Lisbon, PT)

Presentation thumbnail

Transcriptomic analysis of mRNA in mouse model of chronic cigarette smoke-induced endothelial dysfunction treated with recombinant angiotensin-converting enzyme 2

Mr H. Hermawan (Surabaya, ID)

Presentation thumbnail

Ruxolitinib attenuates cardio-renal inflammation via JAK-STAT and CaMKII signaling in hypertension

Ms M. Kiessling (Graz, AT)

Presentation thumbnail

Role and mechanisms of the J1 gene in pulmonary arterial hypertension

Miss J. Ma (Guangzhou, CN)

Access the full session

Session thumbnail

Module B: Mentoring & how-to sessions - Poster rapid fire session 4

The Event

Event poster

Basic Science Course 2026

13 June 2026 12:32 CET

You may be interested in

Congress Presentation

Aberrant interaction between TEAD1 and Lamin A/C causes cardiomyopathy

26 August 2022

Congress Session

Genetics in heart failure

18 May 2025

Congress Presentation

Genetic variants as determinants of outcome in Lamin A/C-related cardiac disease.

29 August 2021

Congress Presentation

LMNA p.Arg624His missense variant reduces lamin expression at mRNA level: elucidating molecular pathways toward cardiac involvement in laminopathies

12 April 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources